We’ve recently updated our valuation analysis.

Huons Global Valuation

Is A084110 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 2/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for A084110?

Other financial metrics that can be useful for relative valuation.

A084110 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.8x
Enterprise Value/EBITDA4.5x
PEG Ration/a

Price to Sales Ratio vs Peers

How does A084110's PS Ratio compare to its peers?

The above table shows the PS ratio for A084110 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average0.6x
A001630 Chong Kun Dang Holdings
A002390 HANDOK
A016580 Whan In PharmLtd
A009290 Kwang Dong Pharmaceutical
A084110 Huons Global

Price-To-Sales vs Peers: A084110 is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (0.6x).

Price to Earnings Ratio vs Industry

How does A084110's PE Ratio compare vs other companies in the KR Pharmaceuticals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a32.9%

Price-To-Sales vs Industry: A084110 is good value based on its Price-To-Sales Ratio (0.4x) compared to the KR Pharmaceuticals industry average (1.1x)

Price to Sales Ratio vs Fair Ratio

What is A084110's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A084110 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.4x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate A084110's Price-To-Sales Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of A084110 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: A084110 (₩19300) is trading above our estimate of fair value (₩10406.26)

Significantly Below Fair Value: A084110 is trading above our estimate of fair value.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies